Colon SurgeryNCT05981937
ICG Anastomosis Control in Colon Surgery
An observational study of Colon Surgery and Anastomotic Leak, run by Azienda Unita Sanitaria Locale di Piacenza at 1 site in Italy.
Trial summary
This is a parallel monocentric, retrospective cohort study in Guglielmo da Saliceto Hospital, Piacenza, Italy. Aim of this study is to investigate the protective role of Indocyanine green (ICG) for Anastomotic leak (AL) in patients underwent elective segmentary colic resection (transverse colic resection, left… Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Colon Surgery, Anastomotic Leak
- What is being tested?
- ICG solution
- Type of treatment
- Injection or infusion
- How many people
- 115 participants
- Where
- 1 siteItaly
- Study dates
- 20 Jul 2023to 1 Feb 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: A consecutive series of patients underwent colo-rectal surgery at our institution between 1 January 2017 and 31 July 2023
Who may be able to join
- elective setting of surgery
- segmentary left colon surgery including transverse resection, splenic flexure resection and left colectomy even for benign or malign pathology
- 30 days of post-operative follow-up at least available from medical documentation
- primary colo-colic or colo-rectal anastomosis with or without preventing ostomy
- more than 18 years old, less than 90 years old
Who cannot join
- terminal colonic stoma without anastomosis creation after demolitive step
- extended transverse right hemicolectomy
- left hemicolectomy with high vascular ligation
- associated bowel or another splanchnic resection (i.e. neoplastic infiltration)
- previous colic surgery
- synchronous neoplasm
Show all 12Show fewer
- not reporting in operating form details about vascular ligation
- lack in reporting in medical records of primary outcomes
- stage IV cancer
- ASA IV
- less than 18 years old, more then 90 years old
- emergency setting
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Indocyanine Green ICG in Segmentary Resection in Colo-rectal Surgery is Usefull to Decrease Leak Threshold: A Paralel Retrospetive Cohort Study
This is a parallel monocentric, retrospective cohort study in Guglielmo da Saliceto Hospital, Piacenza, Italy. Aim of this study is to investigate the protective role of Indocyanine green (ICG) for Anastomotic leak (AL) in patients underwent elective segmentary colic resection (transverse colic resection, left colectomy including sigmoidectomy, splenic colic flexure resection). Secondary aims are to detect and to investigate the impact of various risk factors on AL and morbidity and surgical performance within 30 days to surgery.
Read the detailed description
This is a parallel monocentric, retrospective cohort study observing consecutive series of patients underwent colo-rectal surgery at our institution between 1 January 2017 and 31 July 2023.
The primary endpoint of the study is Anastomotic Leak (AL) at 30 days while secondary endpoints are post-operative morbidity Clavien-Dindo score ≥III within 30 days from surgery including readmission and redo-surgery, harvested nodes for patients with neoplastic disease, Surgical Site Infection, rate of laparoscopic surgical procedure and rate of protection stoma.
Sex, Body Mass Index, smoking, diabetes mellitus, cardiovascular disease, tumor stage according to AJJC 8th edition will be considered confounding factor for onset of AL.
Patients electronic database will be collected from extraction of medical record in operating log and every digital medical record will be scanned including peri-operative outcomes and 30 days post-operative follow-up from post-operative visit, eventually readmission in emergency department or any other specialistic wards of our local health institution according to following inclusion criteria: elective setting of surgery, segmentary left colon surgery: splenic colic resection, transverse colic resection and left colectomy defined as left hemicolectomy with low mesenteric artery-ligation and sigmoidectomy even for benign or malign pathology, at least 30 days of post-operative follow-up available from medical documentation, primary colo-colic or colo-rectal anastomosis with or without preventing ostomy and adult age.
Exclusion criteria are terminal colonic stoma without anastomosis creation after demolitive step, extended transverse right hemicolectomy, left hemicolectomy with high vascular ligation, associated bowel or another splanchnic resection (i.e. neoplastic infiltration), previous colic surgery, synchronous neoplasm, not reporting in operating form details about vascular ligation, lack in reporting in medical records of primary outcomes, stage IV cancer, ASA IV, less than 18 years old and emergency setting.
The reconstruction time is performed with different anastomosis (colo-colic or colo-rectal), technique (stapler or hand sewn) and connection (side to side, side to end, end to side or end to end).
ICG-ATT is available at our institute since 2019 using a near-infrared (NIR) light source and special scope and camera equipped with xenon light (CARL STORZ GmbH \& Co. KG, Tuttlingen, Germany); ICG was supplied as a sterile water-soluble lyophilized powder (Diagnostic Green® GmbH). ICG-ATT is routinely used whenever available in daily practice with the following protocol: after the specimen resection the two colonic stumps or colonic and rectal stumps are checked with 5 cc of ICG 25 mg diluted in 10 cc of water sterile solution before fashioned anastomosis. Two laparoscopes with ICG-optic system are nowadays available department and ICG anastomosis control is always performed if ICG device are available (no performed in case of not available ICG instrument for sterilization in case of two consecutive surgery in the same day, concomitant ICG surgery or ICG malfunction).
Statistical analysis and sample size:
Quantitative variables will be described by mean± standard deviation or median and IQR, and qualitative variables will be described by absolute and percentage frequencies. Normality will be checked for all continuous variables. Comparisons of covariates will be conducted using Pearson's X2 test or Fisher's exact test for categorical variables and a t-test or Mann Whitney test for continuous variables. Univariable analysis will be conducted using logistic regression to examine the association of each predictor variable with the anastomotic leakage event. Next, variables with p<0.1 will be considered for inclusion in a multivariable regression model. For each risk factor, odds ratio with associated confidence intervals will have been presented. All analyses will be performed using RStudio version 3.6.0 statistical software with two-side significance tests and a 5% significance level.
- Conditions
- Colon Surgery, Anastomotic Leak
- Being tested
- ICG solution
- Keywords
- ICG, Colon Surgery, Anastomotic Leak
- Medical subject headings
- Anastomotic Leak
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ICG solutionDrug
Also called Indocyanine Green
ICG-ATT is available at our institute since 2019 using a near-infrared (NIR) light source and special scope and camera equipped with xenon light (CARL STORZ GmbH \& Co. KG, Tuttlingen, Germany); ICG was supplied as a sterile water-soluble lyophilized powder (Diagnostic Green® GmbH). ICG-ATT is routinely used whenever available in daily practice with the following protocol: after the specimen resection the two colonic stumps or colonic and rectal stumps are checked with 5 cc of ICG 25 mg diluted in 10 cc of water sterile solution before fashioned anastomosis. Two laparoscopes with ICG-optic system are nowadays available department and ICG anastomosis control is always performed if ICG device are available (no performed in case of not available ICG instrument for sterilization in case of two consecutive surgery in the same day, concomitant ICG surgery or ICG malfunction).
| Study group | Role | What they receive |
|---|---|---|
| Indocyanine Green | Indocyanine green infusion in left-side colorectal surgery (elective segmentary colic resection) Receives: Drug: ICG solution | |
| non-Indocyanine Green | No infusion of Indocyanine green in left-side colorectal surgery (elective segmentary colic resection ) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Anastomotic leak at 30 days
Anastomotic leak (a defect of intestinal wall at anastomotic site leading to a communication between the intra- and extraluminal compartments)at 30 days: abdominal CT scan IV and a Clavien Dindo Score ≥III
Measured: 30 days
Secondary outcomes (1)
Post-operative morbidity
Clavien-Dindo score ≥III within 30 days from surgery including readmission and redo-surgery, harvested nodes for patients with neoplastic disease, Surgical Site Infection, rate of laparoscopic surgical procedure and rate of protection stoma.
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Aug 2023
- Study start20 Jul 2023
- Primary completion1 Dec 2023
- Study completion1 Feb 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Colon SurgeryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 115 participants (actual)
Sponsor and investigators
- Lead sponsor
- Azienda Unita Sanitaria Locale di Piacenza
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Elena Orlandi, Azienda Unita Sanitaria Locale di Piacenza
- Investigators
- Andrea Romboli, MD, Principal investigator
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05981937
- Sponsor's protocol ID
- GREEN COLONIC SAFE ANASTOMOSIS
- Status last verified
- Mar 2024
- First submitted
- 1 Aug 2023
- Last updated
- 18 Mar 2024
- Results posted
- No
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Romboli A, Orlandi E, Citterio C, Banchini F, Ribolla M, Palmieri G, Giuffrida M, Luzietti E, Capelli P. Indocyanine green in left side colorectal surgery segmental resection to decrease anastomotic leak: A parallel retrospective cohort study of 115 patients. Heliyon. 2024 Oct 24;10(23):e39730. doi: 10.1016/j.heliyon.2024.e39730. eCollection 2024 Dec 15.
PubMed 39687188
Study at a glance
From the registry record, last updated by the sponsor on 18 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Indocyanine Green ICG in Segmentary Resection in Colo-rectal Surgery is Usefull to Decrease Leak Threshold: A Paralel Retrospetive Cohort Study
- ClinicalTrials.gov ID
- NCT05981937
- Acronym / sponsor ID
- GREEN COLONIC SAFE ANASTOMOSIS
- Conditions
- Colon Surgery, Anastomotic Leak
- Keywords
- ICG, Colon Surgery, Anastomotic Leak
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 115 participants (actual)
- Lead sponsor
- Azienda Unita Sanitaria Locale di PiacenzaUniversity, hospital or other
- Study start
- 20 Jul 2023 (actual)
- Primary completion
- 1 Dec 2023 (actual)
- Study completion
- 1 Feb 2024 (actual)
- First posted
- 8 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a parallel monocentric, retrospective cohort study in Guglielmo da Saliceto Hospital, Piacenza, Italy. Aim of this study is to investigate the protective role of Indocyanine green (ICG) for Anastomotic leak (AL) in patients underwent elective segmentary colic resection (transverse colic resection, left colectomy including sigmoidectomy, splenic colic flexure resection). Secondary aims are to detect and to investigate the impact of various risk factors on AL and morbidity and surgical performance within 30 days to surgery.
Detailed description
This is a parallel monocentric, retrospective cohort study observing consecutive series of patients underwent colo-rectal surgery at our institution between 1 January 2017 and 31 July 2023.
The primary endpoint of the study is Anastomotic Leak (AL) at 30 days while secondary endpoints are post-operative morbidity Clavien-Dindo score ≥III within 30 days from surgery including readmission and redo-surgery, harvested nodes for patients with neoplastic disease, Surgical Site Infection, rate of laparoscopic surgical procedure and rate of protection stoma.
Sex, Body Mass Index, smoking, diabetes mellitus, cardiovascular disease, tumor stage according to AJJC 8th edition will be considered confounding factor for onset of AL.
Patients electronic database will be collected from extraction of medical record in operating log and every digital medical record will be scanned including peri-operative outcomes and 30 days post-operative follow-up from post-operative visit, eventually readmission in emergency department or any other specialistic wards of our local health institution according to following inclusion criteria: elective setting of surgery, segmentary left colon surgery: splenic colic resection, transverse colic resection and left colectomy defined as left hemicolectomy with low mesenteric artery-ligation and sigmoidectomy even for benign or malign pathology, at least 30 days of post-operative follow-up available from medical documentation, primary colo-colic or colo-rectal anastomosis with or without preventing ostomy and adult age.
Exclusion criteria are terminal colonic stoma without anastomosis creation after demolitive step, extended transverse right hemicolectomy, left hemicolectomy with high vascular ligation, associated bowel or another splanchnic resection (i.e. neoplastic infiltration), previous colic surgery, synchronous neoplasm, not reporting in operating form details about vascular ligation, lack in reporting in medical records of primary outcomes, stage IV cancer, ASA IV, less than 18 years old and emergency setting.
The reconstruction time is performed with different anastomosis (colo-colic or colo-rectal), technique (stapler or hand sewn) and connection (side to side, side to end, end to side or end to end).
ICG-ATT is available at our institute since 2019 using a near-infrared (NIR) light source and special scope and camera equipped with xenon light (CARL STORZ GmbH \& Co. KG, Tuttlingen, Germany); ICG was supplied as a sterile water-soluble lyophilized powder (Diagnostic Green® GmbH). ICG-ATT is routinely used whenever available in daily practice with the following protocol: after the specimen resection the two colonic stumps or colonic and rectal stumps are checked with 5 cc of ICG 25 mg diluted in 10 cc of water sterile solution before fashioned anastomosis. Two laparoscopes with ICG-optic system are nowadays available department and ICG anastomosis control is always performed if ICG device are available (no performed in case of not available ICG instrument for sterilization in case of two consecutive surgery in the same day, concomitant ICG surgery or ICG malfunction).
Statistical analysis and sample size:
Quantitative variables will be described by mean± standard deviation or median and IQR, and qualitative variables will be described by absolute and percentage frequencies. Normality will be checked for all continuous variables. Comparisons of covariates will be conducted using Pearson's X2 test or Fisher's exact test for categorical variables and a t-test or Mann Whitney test for continuous variables. Univariable analysis will be conducted using logistic regression to examine the association of each predictor variable with the anastomotic leakage event. Next, variables with p<0.1 will be considered for inclusion in a multivariable regression model. For each risk factor, odds ratio with associated confidence intervals will have been presented. All analyses will be performed using RStudio version 3.6.0 statistical software with two-side significance tests and a 5% significance level.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Indocyanine Green | – | Drug: ICG solutionIndocyanine green infusion in left-side colorectal surgery (elective segmentary colic resection) |
| non-Indocyanine Green | – | –No infusion of Indocyanine green in left-side colorectal surgery (elective segmentary colic resection ) |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- A consecutive series of patients underwent colo-rectal surgery at our institution between 1 January 2017 and 31 July 2023
Key inclusion criteria (5 listed)
- elective setting of surgery
- segmentary left colon surgery including transverse resection, splenic flexure resection and left colectomy even for benign or malign pathology
- 30 days of post-operative follow-up at least available from medical documentation
- primary colo-colic or colo-rectal anastomosis with or without preventing ostomy
- more than 18 years old, less than 90 years old
Key exclusion criteria (12 listed)
- terminal colonic stoma without anastomosis creation after demolitive step
- extended transverse right hemicolectomy
- left hemicolectomy with high vascular ligation
- associated bowel or another splanchnic resection (i.e. neoplastic infiltration)
- previous colic surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ICG solutionAlso: Indocyanine GreenICG-ATT is available at our institute since 2019 using a near-infrared (NIR) light source and special scope and camera equipped with xenon light (CARL STORZ GmbH \& Co. KG, Tuttlingen, Germany); ICG was supplied as a sterile water-soluble lyophilized powder (Diagnostic Green® GmbH). ICG-ATT is routinely used whenever available in daily practice with the following protocol: after the specimen resection the two colonic stumps or colonic and rectal stumps are checked with 5 cc of ICG 25 mg diluted in 10 cc of water sterile solution before fashioned anastomosis. Two laparoscopes with ICG-optic system are nowadays available department and ICG anastomosis control is always performed if ICG device are available (no performed in case of not available ICG instrument for sterilization in case of two consecutive surgery in the same day, concomitant ICG surgery or ICG malfunction). | Drug | Indocyanine Green |
Primary outcome
Anastomotic leak at 30 days
Time frame: 30 days
Anastomotic leak (a defect of intestinal wall at anastomotic site leading to a communication between the intra- and extraluminal compartments)at 30 days: abdominal CT scan IV and a Clavien Dindo Score ≥III
1 secondary outcome
Post-operative morbidity
Time frame: 30 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Mar 2024.
- Derived from this study: PubMed 39687188Romboli A, Orlandi E, Citterio C, Banchini F, Ribolla M, Palmieri G, Giuffrida M, Luzietti E, Capelli P. Indocyanine green in left side colorectal surgery segmental resection to decrease anastomotic leak: A parallel retrospective cohort study of 115 patients. Heliyon. 2024 Oct 24;10(23):e39730. doi: 10.1016/j.heliyon.2024.e39730. eCollection 2024 Dec 15.
- Individual participant dataSharing planned: No
Related trials for Colon Surgery
Recruiting
Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery
Colorectal Cancer, Colorectal Surgery
RecruitingObservational study
Evaluation for NCI Surgery Branch Clinical Research Protocols
Synovial Cell Cancer, Melanoma
RecruitingObservational study
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Colorectal Neoplasms, Gastric Neoplasms
RecruitingPhase 1
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Peritoneal Mesothelioma, Peritoneal Carcinomatosis
Not yet recruiting
T1 Colorectal Cancer After Local Excision: Decision Between Surgery and Active Surveillance (T1LDA Trial)
Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andrea Romboli, MD principal investigator
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colon Surgery and Anastomotic Leak, run by Azienda Unita Sanitaria Locale di Piacenza at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Anastomotic leak at 30 days (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05981937, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2024.